ISTH/LinkedIn
Oct 3, 2025, 12:30
ISTH: Advancing Hemophilia Treatment Today and Tomorrow
International Society on Thrombosis and Haemostasis (ISTH) shared a post on LinkedIn:
“New CME opportunity! The hemophilia treatment landscape is rapidly evolving — are you up to date?
Our latest expert-led module, Updates in FVIIa Mimetics: Advancing Hemophilia Treatment Today and Tomorrow, is designed for hematology care teams including physicians, NPs, PAs, nurses and pharmacists.
What you’ll get:
- Key insights into emerging therapies
- Clinical trial updates
- Best practices to individualize patient care”
Start learning today here
Stay updated with Hemostasis Today.
-
Aug 5, 2026, 23:46Recommended ESC Congress Sessions for the ESC Working Group on Thrombosis
-
Aug 5, 2026, 23:36Heghine Khachatryan: ISTH Day 2 – Phase III VAYHIT2 Data Highlights Ianalumab in Primary ITP
-
Aug 5, 2026, 23:28Basyouni Omran: KDIGO 2025/2026 Bedside Guide – Iron Correction in CKD
-
Aug 5, 2026, 23:13C. Michael Gibson: Jean Connors on Antithrombotic Therapy for LVAD at Baim Grand Rounds
-
Aug 5, 2026, 23:07Building Safer Systems for Bleeding and Clotting Care with Dr. Toyosi Onwuemene
-
Aug 5, 2026, 21:19Vidhi Shukla: Anticoagulant Activity of Ficus Racemosa Bark Extract in Rats
-
Aug 5, 2026, 20:30Denis Oduor: Patient Blood Management and Systemic Transfusion Reform
-
Aug 5, 2026, 20:15Salih Ehsan: Diagnostic Screening Strategy for Hemoglobinopathy Traits
-
Aug 5, 2026, 19:39Platelet-Derived Extracellular Vesicles for Hemostasis and Bleeding Reduction in TBI – Every Labs